Nutra Pharma Statistics
Total Valuation
Nutra Pharma has a market cap or net worth of 709,974.
| Market Cap | 709,974 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Nutra Pharma has 7.10 billion shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 7.10B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +108.83% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.20.
| PE Ratio | 0.20 |
| Forward PE | n/a |
| PS Ratio | 2.87 |
| PB Ratio | -0.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -8.06 |
| Interest Coverage | -1.90 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -113.23% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 8.94% |
| Revenue Per Employee | 61,942 |
| Profits Per Employee | 1.78M |
| Employee Count | 4 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 2.22 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 31.45 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 36.40 |
| Average Volume (20 Days) | 13,007 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, Nutra Pharma had revenue of 247,767 and earned 7.11 million in profits. Earnings per share was 0.00.
| Revenue | 247,767 |
| Gross Profit | 66,529 |
| Operating Income | -1.38M |
| Pretax Income | 7.11M |
| Net Income | 7.11M |
| EBITDA | -1.36M |
| EBIT | -1.38M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 8.10M |
| Net Cash | -8.10M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -15.61M |
| Book Value Per Share | -0.00 |
| Working Capital | -15.69M |
Cash Flow
In the last 12 months, operating cash flow was -942,080 and capital expenditures -62,268, giving a free cash flow of -1.00 million.
| Operating Cash Flow | -942,080 |
| Capital Expenditures | -62,268 |
| Free Cash Flow | -1.00M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 26.85%, with operating and profit margins of -557.88% and 2,871.21%.
| Gross Margin | 26.85% |
| Operating Margin | -557.88% |
| Pretax Margin | 2,871.21% |
| Profit Margin | 2,871.21% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Nutra Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -84.73% |
| Shareholder Yield | -84.73% |
| Earnings Yield | 1,002.00% |
| FCF Yield | -141.46% |
Stock Splits
The last stock split was on May 18, 2015. It was a reverse split with a ratio of 0.025.
| Last Split Date | May 18, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.025 |
Scores
Nutra Pharma has an Altman Z-Score of -188.69. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -188.69 |
| Piotroski F-Score | n/a |